StonvexLoading…
StonvexStonvexStonvexCore line items from CMCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.88M | $39.64M | $30.55M | $23.31M |
Operating Income | $-8.42M | $-39.08M | $-27.66M | $-15.14M |
Net Income | $-8.31M | $-39.00M | $-27.57M | $-15.11M |
EPS (Diluted) | $-70.52 | $-67.08 | $-63.18 | $-39.36 |
Total Assets | $792.32M | $859.19M | $871.83M | $885.02M |
Total Liabilities | $535.49M | $592.94M | $588.88M | $584.25M |
Cash & Equivalents | $15.79M | $15.44M | $17.32M | $27.77M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 492.00K | 2.70M | 789.25K | 754.61K |